Why is Dr Reddy's Labs falling/rising?

As of 04-Aug, Dr Reddy's Laboratories Ltd is currently priced at 1,222.00, reflecting a slight increase of 1.4 (0.11%). The stock has shown a trend reversal, gaining after three consecutive days of decline, although it is trading lower than its moving averages across various time frames. Over the past week, the stock has decreased by 5.09%, and it has also underperformed significantly over the past month and year, with returns of -6.37% and -12.21%, respectively. Despite these declines, the company maintains strong long-term fundamentals, including a low debt-to-equity ratio and a healthy return on equity, which contribute to its attractiveness as a potential buy. Additionally, rising investor participation, evidenced by a 53.69% increase in delivery volume, suggests renewed interest in the stock. In the broader market context, Dr Reddy's Laboratories has underperformed compared to the Sensex, which has gained 0.16% over the past week while the stock has fallen. The company's performance has been below par in both the near and long term, with negative returns over the past year and three years. However, the high institutional holdings at 63.1% indicate confidence from larger investors, which may provide some support for the stock. Overall, while the stock has shown a slight uptick today, its recent performance and broader market context suggest ongoing challenges.